Safety and Efficacy Trial of MTX101 2mg for the Acute Treatment of Migraine in Adults
Clinical trial NCT06728553 · COMPLETED
Trial details
- NCT number
- NCT06728553
- Sponsor
- Manistee Therapeutics
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-24
- Primary completion
- 2025-06-27
- Enrollment
- 78
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.